|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00184236 |
|
Date of registration:
|
13/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Cardiovascular Risk Factors in Overweight Adolescents
|
|
Scientific title:
|
Aerobic Interval Training Reduces Cardiovascular Risk Factors More Than a Multitreatment Approach in Overweight Adolescents |
|
Date of first enrolment:
|
February 2005 |
|
Target sample size:
|
54 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00184236 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Norway
| | | | | | | |
|
Contacts
|
|
Name:
|
Ulrik Wisløff, Dr.Philos |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Norwegian University of Science and Technology, St. Olav's Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Overweight and obese adolescents in the Trondheim area, referred to medical treatment at St. Olav's Hospital
Exclusion Criteria:
- Any coexisting medical illnesses
Age minimum:
13 Years
Age maximum:
16 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Obesity
|
|
Overweight
|
|
Intervention(s)
|
|
Behavioral: Aerobic intervention training
|
|
Behavioral: Multitreatment approach
|
|
Primary Outcome(s)
|
|
VO2max change
[Time Frame: 3 months and 12 months]
|
|
Secondary Outcome(s)
|
|
Cardiovascular risk factors
[Time Frame: 2 years]
|
|
endothelial function change
[Time Frame: 3 months and 12 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|